134 related articles for article (PubMed ID: 20387720)
1. Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection.
Vince A; Lepej SZ
Med Glas (Zenica); 2010 Feb; 7(1):18-25. PubMed ID: 20387720
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
4. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Lie AK; Kristensen G
Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
[TBL] [Abstract][Full Text] [Related]
6. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
Isidean SD; Coutlée F; Franco EL
Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
[TBL] [Abstract][Full Text] [Related]
7. High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?
Twiggs LB; Hopkins M
J Low Genit Tract Dis; 2011 Jul; 15(3):224-30. PubMed ID: 21716051
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China.
Yang L; Yang H; Wu K; Shi X; Ma S; Sun Q
J Med Virol; 2014 Nov; 86(11):1926-36. PubMed ID: 25111286
[TBL] [Abstract][Full Text] [Related]
9. [Methods of HPV detection in exfoliated cells and tissue specimens approved by the United States Food and Drug Administration].
Zhao CQ; Yang HT; Tian ZD; Huang WB
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):855-7. PubMed ID: 23324242
[No Abstract] [Full Text] [Related]
10. [Identification and genotyping of oncogenic type of human papillomavirus in paraffin-embedded cervical cancer samples in Guangzhou].
Zeng L; Yu SY; Gou SQ; Yun JP; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2485-7. PubMed ID: 20034908
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HPV genotypes in women with cervical cancer in Auckland, New Zealand; a review of 50 specimens between 2000-2006.
Williamson D; Nagappan R; Sirikonda R; Rahnama F; Thomas S; Lovell-Smith M; Croxson M
Aust N Z J Obstet Gynaecol; 2011 Feb; 51(1):67-70. PubMed ID: 21299512
[TBL] [Abstract][Full Text] [Related]
12. Electrochemical chip-based genomagnetic assay for detection of high-risk human papillomavirus DNA.
Bartosik M; Durikova H; Vojtesek B; Anton M; Jandakova E; Hrstka R
Biosens Bioelectron; 2016 Sep; 83():300-5. PubMed ID: 27132004
[TBL] [Abstract][Full Text] [Related]
13. Laboratory diagnosis of human papillomavirus infection.
Ikenberg H
Curr Probl Dermatol; 2014; 45():166-74. PubMed ID: 24643185
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
15. Cervical samples dried on filter paper and dried vaginal tampons can be useful to investigate the circulation of high-risk HPV in Congo.
Alidjinou EK; Ebatetou-Ataboho E; Sané F; Moukassa D; Dewilde A; Hober D
J Clin Virol; 2013 Jun; 57(2):161-4. PubMed ID: 23478164
[TBL] [Abstract][Full Text] [Related]
16. The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studies.
Poljak M; Oštrbenk A
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(2):43-7. PubMed ID: 23836358
[TBL] [Abstract][Full Text] [Related]
17. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil.
Fernandes JV; Meissner Rde V; Carvalho MG; Fernandes TA; Azevedo PR; de Azevedo JW; de Araújo JM
Mol Med Rep; 2011; 4(6):1321-6. PubMed ID: 21887467
[TBL] [Abstract][Full Text] [Related]
19. HPV detection methods and genotyping techniques in screening for cervical cancer.
Eide ML; Debaque H
Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of E6/E7 mRNAs of high risk human papilloma virus types by a commercial automatized NASBA assay in cervical swabs].
Ardiç N; Oztürk O; Ergünay K; Sezer O
Mikrobiyol Bul; 2009 Jul; 43(3):463-9. PubMed ID: 19795622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
